Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4271
+0.0065 (1.55%)
At close: Apr 25, 2025, 4:00 PM
0.4390
+0.0119 (2.79%)
Pre-market: Apr 28, 2025, 7:00 AM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $28.62 million as of April 28, 2025. Its market cap has decreased by -88.40% in one year.
Market Cap
28.62M
Enterprise Value
-63.04M
1-Year Change
-88.40%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $28.62M, a decrease of -97.33%. That is a compound annual growth rate of -52.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 28.62M | -59.57% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.47B |
| UnitedHealth Group | 379.88B |
| Johnson & Johnson | 369.43B |
| AbbVie | 329.61B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.53B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |